Course Provider
Learning Objectives
Upon completion of this activity, participants should be better able to identify appropriate patient- and disease-specific factors to inform treatment planning for patients with MIBC who may be candidates for perioperative immunotherapy
Upon completion of this activity, participants should be better able to evaluate the latest data on safety and efficacy from pivotal clinical trials leading to new FDA approvals and guideline updates for multimodal treatment approaches in MIBC
Upon completion of this activity, participants should be better able to assess emerging clinical data on perioperative immunotherapy approaches
Upon completion of this activity, participants should be better able to employ interprofessional strategies to conduct up-front multidisciplinary treatment planning and monitoring for patients with MIBC
Upon completion of this activity, participants should be better able to improve multidisciplinary supportive care services to monitor and mitigate adverse events associated with multimodal treatment approaches